Company news
Spectral Medical Inc (TSX:EDT) news
Spectral Medical Inc news releases on 6ix. Latest, Jun 6, 2007: Spectral's EAA(TM) Proven Effective in Veterinary Applications
Press releases — page 4
Spectral's EAA(TM) Proven Effective in Veterinary Applications
June 6, 2007
Spectral and Menarini sign European EAA(TM) distribution agreement
May 22, 2007
Spectral and Estor strengthen EAA(TM) market position in Italy
May 16, 2007
Spectral reports first quarter results
May 9, 2007
Spectral's RapidWN West Nile Virus IgM Test presented at Oak Ridge Conference
April 19, 2007
Spectral's EAA(TM) to be featured at The International Symposium of Intensive Care and Emergency Medicine
March 26, 2007
Spectral Announces Significant EAA(TM) Presentations at 7th World TSIS Congress
March 13, 2007
Spectral Announces Financial Results
March 8, 2007
Spectral to Present at the 11th Annual Japanese Society of Critical Care and Endotoxemia on the use of EAA(TM) in Critically Ill Patients
February 9, 2007
Market Regulation Services - Trade Resumption - Spectral Diagnostics Inc. - SDI
December 12, 2006
FDA approves Spectral's rapid West Nile Virus test
December 12, 2006
Market Regulation Services - Trading Halt - Spectral Diagnostics Inc. - SDI
December 12, 2006
Spectral expands EAA(TM) placement in leading European hospitals
November 30, 2006
Spectral reports improved second quarter operating results
November 9, 2006
Spectral and Estor expand distribution relationship
October 16, 2006
Spectral announces the appointment of Mr. Guillermo Herrera to its Board of Directors
September 22, 2006
Spectral announces first quarter earnings
August 10, 2006
SPECTRAL AND JUSTE announce Spanish Distribution Agreement for EAA(TM)
August 2, 2006
CMDF Funds Acquire Shares of Spectral Diagnostics
July 28, 2006
Spectral Presents Data on West Nile Virus Rapid 1 Assay at the American Association for Clinical Chemistry (AACC) Meeting
July 24, 2006
Spectral'S Endotoxin Activity Assay (EAA(TM)) Systems placed in Italy
July 11, 2006
Spectral announces distribution agreement for Endotoxin Activity Assay (EAA(TM)) with Estor, SpA, in Italy
June 22, 2006
Spectral reports financial results for 2006
June 14, 2006
Spectral announces settlement of $10 million debt
June 12, 2006
Spectral announces strategic alliance with Toray Medical for sepsis managment
June 8, 2006
Spectral and Somagen announce Canadian Distribution Agreement for Rapid West Nile Virus Test
June 1, 2006
Spectral announces board and management appointments
April 6, 2006
Spectral reports third quarter results
February 14, 2006
Spectral closes sale of rapid cardiac immunoassay test business
February 7, 2006
Spectral announces shareholder approval for sale of rapid cardiac test business
January 20, 2006
Nanogen and Spectral announce rapid cardiac diagnostic test agreement
December 20, 2005
Spectral Diagnostics Inc. reports results for the second quarter ended September 30, 2005
November 9, 2005
Spectral Diagnostics contributes to the first International Sepsis Forum Biomarker Conference
November 7, 2005
Spectral Diagnostics and IDx receive Canadian regulatory approval for the West Nile Virus STATus Rapid Test
November 2, 2005
Spectral Diagnostics Inc. reports first quarter results
August 9, 2005
Spectral Diagnostics and IDx report achievement of major milestone in the development of a rapid test for West Nile Virus infection
August 4, 2005
Spectral's new i-Lynx(TM) instrument shows positive market acceptance
July 13, 2005
Spectral Diagnostics Inc. reports financial results for the year ended March 31, 2005
June 9, 2005